CLINICAL_TRIALS
trial_result
· 2024-09-04
Clinical Trial Update: A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes [Phase 1]
Summary
Phase 1 multiple-dose study of LY3209590 in participants with type 2 diabetes; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED